戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 3036作成日:2026年10月23日

Pyridine, hydrofluoride (1:1) → methyl(11R,12S,13E)-9-butyryloxy-11,15-dihydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoate

https://huagongshe.com/ja/reaction/3036

反応式

関与物質

役割名称HCID仕込み量
反応物Pyridine, hydrofluoride (1:1)HCID 64774—
反応物methyl(11R,12S,13E)-9-butyryloxy-11-tert-butyldimethylsiloxy-15-hydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoateHCID 22883818—
生成物methyl(11R,12S,13E)-9-butyryloxy-11,15-dihydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoateHCID 22883815—

反応手順

Using as the materials a hydrogen fluoride-pyridine solution (0.25 ml) and methyl(11R,12S,13E)-9-butyryloxy-11-tert-butyldimethylsiloxy-15-hydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoate (100 mg), the same procedure as in Example 2 was performed to separately obtain two stereoisomers of methyl(11R,12S,13E)-9-butyryloxy-11,15-dihydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoate different at the 15-position. (Low polarity compound: 26 mg, 33%; high polarity compound: 28 mg, 35%)

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US05731452
出典データセットuspto-grants-1998_03
ORD IDord-e387f53034b342bebeac204bcb29c54a
出典メモuspto-grants-1998_03